2 unknown, 1 completed, 1 terminated. 4 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 2, Completed 1, Terminated 1 |
| Phase 1 | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow Chlorotoxin: new trials by email Literature Review of Chlorotoxin trials Research Report on Chlorotoxin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma 131I-TM601 - Malignant Glioma, Glioblastoma Multiforme | Phase 1 / Phase 2 | Unknown | TransMolecular | 64 | 2008-08-01 | 2009-07-17 |
| 131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma 131-I-TM-601, 131I-TM601 - Malignant Glioma, Glioblastoma Multiforme | Phase 2 | Unknown | TransMolecular | 66 | 2004-11-01 | 2009-04-03 |
| Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma. 131I-TM-601 - Glioma, Brain Neoplasm | Phase 1 / Phase 2 | Completed | TransMolecular | 18 | 2002-06-01 | 2009-03-31 |
| A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma 131I-TM601 - Melanoma, Malignant Melanoma | Phase 1 / Phase 2 | Terminated | TransMolecular | 58 | 2009-05-11 |
Brain Neoplasms (3) · Glioma (3) · Astrocytoma (2) · Glioblastoma (2) · Gliosarcoma (1) · Melanoma (1) · Oligodendroglioma (1)
TransMolecular (4)
United States (4)
John Fiveash, MD (2) · Thomas Gribbin, MD (2) · Adam Mamelak, MD (1) · Anna Pavlick, DO (1) · Antonio Omuro, MD (1) · David Schiff, MD (1) · Diana M Hablitz, MSNCRNP (1) · Edward Pan, MD (1) · Heather Jacene, MD (1) · Jan Drappatz, MD (1) · Jay-Jiguang Zhu, MD (1) · Jeffrey Olson, MD (1) · Jeffrey Raizer, MD (1) · Karen Fink, MD (1) · Maciej Mrugala, MD (1)